“FDA approves new monoclonal antibody for hospitalized COVID-19 patients” 12/21/22
thehill.com/policy/healthc…
thehill.com/policy/healthc…
https://twitter.com/Shiloh1950/status/1605787955045355525
“The drug, called Actemra, was originally approved in 2010 to treat adult patients with moderate to severe rheumatoid arthritis. The company says that is the first FDA-approved monoclonal antibody intended to treat patients with severe cases of COVID-19.”
“…is intended for the treatment of #C19 in hospitalized adult patients who are receiving certain steroids & require supplemental oxygen, mech ventilation or are on life support through extracorporeal membrane oxygenation. It is recommended for use as a single 60-min IV infusion”
“Last year, the FDA authorized the emergency use of Actemra
to treat severe cases of COVID-19 in adults & children between
the ages of 2 & 17.
That authorization remains in place, the company said.”
to treat severe cases of COVID-19 in adults & children between
the ages of 2 & 17.
That authorization remains in place, the company said.”
H/T @Shiloh1950
• • •
Missing some Tweet in this thread? You can try to
force a refresh
